Drawing for PCI PHARMA SERVICES

USPTO serial 99063906

PCI PHARMA SERVICES

Reviewed by CopyMark Law Group

Status 653
Filing date
Status date
Registration date
—
Examiner
SAXTON, EVELYN H
Law office
TMO LAW OFFICE 112

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with PCI PHARMA SERVICES?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Richard E. Peirce

Richard E. Peirce Eckert Seamans Cherin & Mellott, LLC50 S. 16th Street, 22nd FloorPhiladelphia, PA 19102-2516United States

Goods and services

ClassDescriptionStatusFirst use
039Packaging and labeling of pharmaceutical materials used in clinical trials for others; biologics packaging for others; packaging pharmaceutical and health care products to the order and specification of others; logistical services for others, namely, the storage, transportation and delivery of pharmaceutical products to clinical research trialsACTIVE—
040Custom manufacture of pharmaceuticals; Custom manufacture of biopharmaceuticals; Biomanufacture of pharmaceuticals to order and specification of others; Manufacturing of pharmaceutical dosage forms for othersACTIVE—
042Pharmaceutical drug development servicesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 23, 2026GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Sep 23, 2026GNSLLETTER OF SUSPENSION E-MAILED—
Sep 23, 2026CNSLSUSPENSION LETTER WRITTEN—
Jun 23, 2026ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Jun 23, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 15, 2026DOCKASSIGNED TO EXAMINER—
Feb 17, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 17, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 17, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 13, 2025XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED—
Nov 13, 2025XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED—
Aug 17, 2025GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 17, 2025GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 17, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 5, 2025DOCKASSIGNED TO EXAMINER—
Jul 23, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 13, 2025TAEATEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED—
Jun 13, 2025PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Mar 3, 2025NWAPNEW APPLICATION ENTERED—
Mar 3, 2025MAFRAPPLICATION FILING RECEIPT MAILED—

Frequently asked questions

Related guidance